Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,177
archived clinical trials in
Orthopedic

The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Altamonte Springs, FL
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Altamonte Springs, FL
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Atlantis, FL
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Jacksonville, FL
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Kissimmee, FL
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Kissimmee, FL
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Longwood, FL
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Longwood, FL
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Miami, FL
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Ormond Beach, FL
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Pembroke Pines, FL
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Evanston, IL
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Evanston, IL
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Vernon Hills, IL
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Vernon Hills, IL
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Fort Wayne, IN
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Indianapolis, IN
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Scarborough, ME
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Scarborough, ME
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Baltimore, MD
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Columbia, MD
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Columbia, MD
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Pikesville, MD
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Pikesville, MD
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Grand Rapids, MI
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Edina, MN
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Edina, MN
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Minneapolis, MN
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Camden, NJ
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Camden, NJ
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Buffalo, NY
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
New York, NY
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Williamsville, NY
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Williamsville, NY
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Fayetteville, NC
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Fayetteville, NC
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Greensboro, NC
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Greensboro, NC
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Winston-Salem, NC
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Cincinnati, OH
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Cleveland, OH
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Hillsboro, OR
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Hillsboro, OR
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Portland, OR
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Allentown, PA
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Allentown, PA
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Camp Hill, PA
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Camp Hill, PA
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Doylestown, PA
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Doylestown, PA
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Philadelphia, PA
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Pittsburgh, PA
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
West Grove, PA
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
West Grove, PA
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Warwick, RI
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Warwick, RI
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Columbia, SC
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Columbia, SC
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Greenville, SC
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Greenville, SC
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Greer, SC
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Greer, SC
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Kingsport, TN
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Kingsport, TN
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Knoxville, TN
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Nashville, TN
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Houston, TX
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Danville, VA
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Danville, VA
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Roanoke, VA
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Roanoke, VA
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Springfield, VA
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Springfield, VA
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Tacoma, WA
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated:  11/5/2015
GSK Investigational Site
mi
from
Milwaukee, WI
The CLEVER Study - Coreg And Left Ventricular Mass Regression
A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).
Status: Enrolling
Updated: 11/5/2015
GSK Investigational Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation in Patients With Multiple Sclerosis
Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation on Walking and Cortical Activation in Patients With Multiple Sclerosis.
Status: Enrolling
Updated:  11/6/2015
Cleveland Clinic Neurological Institute Mellen Center
mi
from
Cleveland, OH
Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation in Patients With Multiple Sclerosis
Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation on Walking and Cortical Activation in Patients With Multiple Sclerosis.
Status: Enrolling
Updated: 11/6/2015
Cleveland Clinic Neurological Institute Mellen Center
mi
from
Cleveland, OH
Click here to add this to my saved trials